Gastrins, cholecystokinins and gastrointestinal cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1704, Issue 1, 2004, Pages 1-10

  Aly, Ahmad ^a   Shulkes, Arthur ^a   Baldwin, Graham S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

amidated gastrin17; CCK; cholecystokinin; Colorectal cancer; COX 2; cyclooxygenase 2; Gamide; Gastric cancer; Gastrin; Ggly; glycine extended gastrin17; Migration; Pancreatic cancer; Proliferation

Indexed keywords

ANTISERUM; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; DIPHTHERIA VACCINE; GASTRIN; GASTRIN ANTAGONIST; GASTRIN RECEPTOR; GLYCINE; NONSTEROID ANTIINFLAMMATORY AGENT; PEPTIDE DERIVATIVE; PROGASTRIN;

CANCER CELL CULTURE; CANCER GROWTH; CARCINOID; CELL MIGRATION; CELL PROLIFERATION; CLINICAL TRIAL; COLON MUCOSA; COLORECTAL CARCINOMA; DRUG MECHANISM; GASTROINTESTINAL CARCINOMA; HUMAN; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; STOMACH CARCINOMA;

CHOLECYSTOKININ; COLORECTAL NEOPLASMS; GASTRINS; GASTROINTESTINAL NEOPLASMS; HUMANS; PANCREATIC NEOPLASMS; RECEPTORS, CHOLECYSTOKININ; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

ANIMALIA; HELICOBACTER; HELICOBACTER PYLORI;

EID: 3042676790     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2004.01.004     Document Type: Review

References (129)

1. McGuigan J. Gastrin mucosal intracellular localisation by immunofluorescence. Gastroenterology. 55:1968;315-327
2. Baldwin G.S., Shulkes A. Gastrin, gastrin receptors and colorectal cancer. Gut. 42:1998;581-584
3. Seva C., Dickinson C., Yamada T. Growth-promoting effects of glycine-extended progastrin. Science. 265:1994;410-412
4. Stepan V.M., Krametter D.F., Matsushima M., Todisco A., Delvalle J., Dickinson C.J. Glycine-extended gastrin regulates HEK cell growth. Am. J. Physiol. 277:1999;R572-R581
5. Baldwin G.S., Curtain C.C., Sawyer W.H. Selective, high-affinity binding of ferric ions by glycine-extended gastrin(17). Biochemistry. 40:2001;10741-10746
6. Pannequin J., Barnham K.J., Hollande F., Shulkes A., Norton R.S., Baldwin G.S. Ferric ions are essential for the biological activity of the hormone glycine-extended gastrin. J. Biol. Chem. 277:2002;48602-48609
7. Baldwin G.S., Hollande F., Yang Z., Karelina Y., Paterson A., Strang R., Fourmy D., Neumann G., Shulkes A. Biologically active recombinant human progastrin(6-80) contains a tightly bound calcium ion. J. Biol. Chem. 276:2001;7791-7796
8. Singh P., Lu X.B., Cobb S.L., Miller B.T., Tarasova N., Varro A., Owlia A. The prohormone, progastrin1-80, stimulates growth of intestinal epithelial cells in vitro via high affinity binding sites. Am. J. Physiol. 284:2003;G328-G339
9. Shulkes A., Baldwin G.S. Biology of gut cholecystokinin and gastrin receptors. Clin. Exp. Pharmacol. Physiol. 24:1997;209-216
10. Baldwin G.S. The 78 kDa gastrin binding protein is a candidate receptor for autocrine progastrin. FEBS Lett. 359:1995;97-100
11. Weinstock J., Baldwin G.S. Binding of gastrin to human gastric carcinoma cell lines. Cancer Res. 48:1988;932-937
12. Baldwin G.S. Antiproliferative gastrin/cholecystokinin receptor antagonists target the 78 kDa gastrin binding protein. Proc. Natl. Acad. Sci. U. S. A. 91:1994;7593-7597
13. Baldwin G.S. Comparison of sequences of the 78 kDa gastrin binding protein and some enzymes involved in fatty acid oxidation. Comp. Biochem. Physiol. 104B:1993;55-61
14. Mantyh C.R., Pappas T.N., Vigna S.R. Localization of cholecystokinin A and cholecystokinin B/gastrin receptors in the canine upper gastrointestinal tract. Gastroenterology. 107:1994;1019-1030
15. Reubi J.C., Waser B., Laderach U., Stettler C., Friess H., Halter F., et al. Localization of cholecystokinin A and cholecystokinin B-gastrin receptors in the human stomach. Gastroenterology. 112:1997;1197-1205
16. Helander H.F., Wong H., Poorkhalkali N., Walsh J.H. Immunohistochemical localization of gastrin/CCK-2 receptors in the dog and guinea-pig stomach. Acta Physiol. Scand. 159:1997;313-320
17. Kulaksiz H., Arnold R., Goke B., Maronde E., Meyer M., Fahrenholz F., et al. Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res. 299:2000;289-298
18. Monstein H.J., Nylander A.G., Salehi A., Chen D., Lundquist I., Hakanson R. Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand. J. Gastroenterol. 31:1996;383-390
19. Weinberg D.S., Ruggeri B., Barber M.T., Biswas S., Miknyocki S., Waldman S.A. Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J. Clin. Invest. 100:1997;597-603
20. Tang C., Biemond I., Lamers C.B. Cholecystokinin receptors in human pancreas and gallbladder muscle: a comparative study. Gastroenterology. 111:1996;1621-1626
21. Saillan-Barreau C., Dufresne M., Clerc P., Sanchez D., Corominola H., Moriscot C., Guy-Crotte O., Escrieut C., Vaysse N., Gomis R., Tarasova N., Fourmy D. Evidence for a functional role of the cholecystokinin-B/gastrin receptor in the human fetal and adult pancreas. Diabetes. 48:1999;2015-2021
22. Schmitz F., Otte J.M., Stechele H.U., Reimann B., Banasiewicz T., Folsch U.R., et al. CCK-2/gastrin receptors in human colorectal cancer. Eur. J. Clin. Investig. 31:2001;812-820
23. Lehy T. Trophic effect of some regulatory peptides on gastric exocrine and endocrine cell of the rat. Scand. J. Gastroenterol. 19(Suppl. 101):1984;27-30
24. Kirton C.M., Wang T., Dockray G.J. Regulation of parietal cell migration by gastrin in the mouse. Am. J. Physiol. 283:2002;G787-G793
25. Kidd M., Modlin I., Tang L. Gastrin and the enterochromaffin like cell: an update. Dig. Surg. 15:1998;209-217
26. Hakanson R., Axelson J., Ekman R., Sundler F. Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines. Regulatory Pept. 23:1988;105-115
27. FitzGerald A.J., Ghatei M.A., Mandir N., Bloom S.R., Iversen L., Goodlad R.A. Effects of amidated gastrin and glycine-extended gastrin on cell proliferation and crypt fission in parenterally and orally fed rats. Digestion. 66:2002;58-66
28. Chen D., Nylander A.G., Norlen P., Hakanson R. Gastrin does not stimulate growth of the rat pancreas. Scand. J. Gastroenterol. 31:1996;404-410
29. Rooman I., Lardon J., Flamez D., Schuit F., Bouwens L. Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology. 121:2001;940-949
30. Rooman I., Lardon J., Bouwens L. Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes. 51:2002;686-690
31. Lacourse K.A., Swanberg L.J., Gillespie P.J., Rehfeld J.F., Saunders T.L., Samuelson L.C. Pancreatic function in CCK-deficient mice: adaptation to dietary protein does not require CCK. Am. J. Physiol. 276:1999;G1302-G1309
32. Kopin A.S., Mathes W.F., McBride E.W., Nguyen M., Al-Haider W., Schmitz F., et al. The cholecystokinin-A receptor mediates inhibition of food intake yet is not essential for the maintenance of body weight. J. Clin. Invest. 103:1999;383-391
33. Takiguchi S., Takata Y., Funakoshi A., Miyasaka K., Kataoka K., Fujimura Y., et al. Disrupted cholecystokinin type-A receptor (CCKAR) gene in OLETF rats. Gene. 197:1997;169-175
34. Kanemoto N., Kondo M., Iwanaga T., Hishigaki H., Ono T., Mizoguchi-Miyakita A., et al. Genetic analysis of pancreatic duct hyperplasia in Otsuka Long-Evans Tokushima Fatty rats: possible association with a region on rat chromosome 14 that includes the disrupted cholecystokinin-A receptor gene. Pathol. Int. 51:2001;133-139
35. Koh T.J., Goldenring J.R., Ito S., Mashimo H., Kopin A.S., Varro A., et al. Gastrin deficiency results in altered gastric differentiation and decreased colonic proliferation in mice. Gastroenterology. 113:1997;1015-1025
36. Wang T.C., Koh T.J., Varro A., Cahill R.J., Dangler C.A., Fox J.G., Dockray G.J. Processing and proliferative effects of human progastrin in transgenic mice. J. Clin. Invest. 98:1996;1918-1929
37. Koh T.J., Dockray G.J., Varro A., Cahill R.J., Dangler C.A., Fox J.G., et al. Overexpression of glycine extended gastrin in transgenic mice results in increased colonic proliferation. J. Clin. Invest. 103:1999;1119-1126
38. Aly A., Baldwin G., Shulkes A. Short term infusion of glycine extended gastrin (17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa. Int. J. Cancer. 94:2001;307-313
39. Kelly A., Hollande F., Shulkes A., Baldwin G.S. Expression of progastrin-derived peptides and gastrin receptors in a panel of gastrointestinal carcinoma cell lines. J. Gastroenterol. Hepatol. 13:1998;208-214
40. Baldwin G.S. The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth. J. Gastroenterol. Hepatol. 10:1995;215-232
41. Iwase K., Evers B.M., Hellmich M.R., Guo Y.S., Higashide S., Kim H.J., et al. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology. 113:1997;782-790
42. Hollande F., Choquet A., Blanc E.M., Lee D.J., Bali J.P., Baldwin G.S. Involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinases in glycine-extended gastrin-induced dissociation and migration of gastric epithelial cells. J. Biol. Chem. 276:2001;40402-40410
43. Mandair K.K., Towner P., Stamford I.F., Morris J.D., Harper E., Benjamin I.S., et al. Cholecystokinin receptors in human pancreatic cancer cell lines. Eur. J. Cancer. 34:1998;1455-1459
44. de Weerth A., von Schrenck T., Lohr M., Mirau S., Greten H., Kalthoff H. Human pancreatic cancer cell lines express the CCKB receptor. Hepato-gastroenterol. 46:1999;472-478
45. Monstein H.J., Ohlsson B., Axelson J. Differential expression of gastrin, cholecystokinin-A and cholecystokinin-B receptor mRNA in human pancreatic cancer cell lines. Scand. J. Gastroenterol. 36:2001;738-743
46. Smith J.P., Fantaskey A.P., Liu G., Zagon I.S. Identification of gastrin as a growth peptide in human pancreatic cancer. Am. J. Physiol. 268:1995;R135-R141
47. Kaufmann R., Schafberg H., Rudroff C., Henklein P., Nowak G. Cholecystokinin B-type receptor signaling is involved in human pancreatic cancer cell growth. Neuropeptides. 31:1997;573-583
48. Douziech N., Lajas A., Coulombe Z., Calvo E., Laine J., Morisset J. Growth effects of regulatory peptides and intracellular signaling routes in human pancreatic cancer cell lines. Endocrine. 9:1998;171-183
49. Smith J.P., Shih A., Wu Y., McLaughlin P.J., Zagon I.S. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. Am. J. Physiol. 270:1996;R1078-R1084
50. Smith J.P., Verderame M.F., Zagon I.S. Antisense oligonucleotides to gastrin inhibit growth of human pancreatic cancer. Cancer Lett. 135:1999;107-112
51. Ohlsson B., Fredang N., Axelson J. The effect of bombesin, cholecystokinin, gastrin, and their antagonists on proliferation of pancreatic cancer cell lines. Scand. J. Gastroenterol. 34:1999;1224-1229
52. Singh P., Owlia A., Espeijo R., Dai B. Novel gastrin receptors mediate mitogenic effects of gastrin and processing intermediates of gastrin on Swiss 3T3 fibroblasts. Absence of detectable cholecystokinin (CCK)-A and CCK-2 receptors. J. Biol. Chem. 270:1995;8429-8438
53. Hollande F., Imdahl A., Mantamadiotis T., Ciccotosto G.D., Shulkes A., Baldwin G.S. Glycine-extended gastrin acts as an autocrine growth factor in a nontransformed colon cell line. Gastroenterology. 113:1997;1576-1588
54. Stepan V.M., Sawada M., Todisco A., Dickinson C.J. Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells. Mol. Med. 5:1999;147-159
55. Litvak D.A., Hellmich M.R., Iwase K., Evers B.M., Martinez J., Amblard M., et al. JMV1155: a novel inhibitor of glycine-extended progastrin-mediated growth of a human colon cancer in vivo. Anticancer Res. 19:1999;45-49
56. Hirata M., Itoh M., Tsuchida A., Ooishi H., Hanada K., Kajiyama G. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS. Lett. 383:1996;241-244
57. Hirata M., Tsuchida A., Iwao T., Sasaki T., Matsubara K., Yamamoto S., et al. Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. Int. J. Oncol. 14:1999;1129-1135
58. Wroblewski L.E., Pritchard D.M., Carter S., Varro A. Gastrin-stimulated gastric epithelial cell invasion: the role and mechanism of increased matrix metalloproteinase 9 expression. Biochem. J. 365:2002;873-879
59. Pagliocca A., Wroblewski L.E., Ashcroft F.J., Noble P.J., Dockray G.J., Varro A. Stimulation of the gastrin-cholecystokinin(B) receptor promotes branching morphogenesis in gastric AGS cells. Am. J. Physiol. 283:2002;G292-G299
60. Schmassmann A., Reubi J.C. Cholecystokinin-B/gastrin receptors enhance wound healing in the rat gastric mucosa. J. Clin. Invest. 106:2000;1021-1029
61. Kermorgant S., Lehy T. Glycine-extended gastrin promotes the invasiveness of human colon cancer cells. Biochem. Biophys. Res. Commun. 285:2001;136-141
62. Hakanson R., Chen D., Andersson K., Monstein H.J., Zhao C.M., Ryberg B., et al. The biology and physiology of the ECL cell. Yale J. Biol. Med. 67:1994;123-134
63. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J. Surg. 20:1996;168-172
64. Peghini P.L., Annibale B., Azzoni C., Milione M., Corleto V.D., Gibril F., et al. Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology. 123:2002;68-85
65. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345:2001;784-789
66. Fox J.G., Wang T.C. Helicobacter pylori - not a good bug after all. New Engl. J. Med. 345:2001;829-832
67. Israel D.A., Salama N., Arnold C.N., Moss S.F., Ando T., Wirth H.P., et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J. Clin. Invest. 107:2001;611-620
68. Houghton J., Fox J.G., Wang T.C. Gastric cancer: laboratory bench to clinic. J. Gastroenterol. Hepatol. 17:2002;495-502
69. Chowers M.Y., Keller N., Tal R., Barshack I., Lang R., Bar-Meir S., et al. Human gastrin: a Helicobacter pylori-specific growth factor. Gastroenterology. 117:1999;1113-1118
70. Wang T.C., Dangler C.A., Chen D., Goldenring J.R., Koh T., Raychowdhury R., et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology. 118:2000;36-47
71. Fox J.G., Rogers A.B., Ihrig M., Taylor N.S., Whary M.T., Dockray G., Varro A., Wang T.C. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res. 63:2003;942-950
72. Watson S.A., Durrant L.G., Wencyk P.M., Watson A.L., Morris D.L. Intracellular gastrin in human gastrointestinal tumor cells. J. Natl. Cancer Inst. 83:1991;866-871
73. Okada N., Kubota A., Imamura T., Suwa H., Kawaguchi Y., Ohshio G., et al. Evaluation of cholecystokinin, gastrin, CCK-1 receptor, and CCK-2/gastrin receptor gene expressions in gastric cancer. Cancer Lett. 106:1996;257-262
74. Reubi J.C., Waser B., Schmassmann A., Laissue J.A. Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located? Int. J. Cancer. 81:1999;376-386
75. Henwood M., Clarke P.A., Smith A.M., Watson S.A. Expression of gastrin in developing gastric adenocarcinoma. Br. J. Surg. 88:2001;564-568
76. Tang C., Biemond I., Offerhaus G.J., Verspaget W., Lamers C.B. Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas. Br. J. Cancer. 75:1997;1467-1473
77. Moonka R., Zhou W., Bell R.H. Jr. Cholecystokinin-A receptor messenger RNA expression in human pancreatic cancer. J. Gastrointest. Surg. 3:1999;134-140
78. Caplin M., Savage K., Khan K., Brett B., Rode J., Varro A., et al. Expression and processing of gastrin in pancreatic adenocarcinoma. Br. J. Surg. 87:2000;1035-1040
79. Goetze J.P., Nielsen F.C., Burcharth F., Rehfeld J.F. Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer. 88:2000;2487-2494
80. Upp J.R. Jr., Singh P., Townsend C.M. Jr., Thompson J.C. Clinical significance of gastrin receptors in human colon cancers. Cancer Res. 49:1989;488-492
81. Wong K., Beardshall K., Waters C.M., Calam J., Poston G.J. Postprandial hypergastrinaemia in patients with colorectal cancer. Gut. 32:1991;1352-1354
82. Kochman M.L., DelValle J., Dickinson C.J., Boland C.R. Post-translational processing of gastrin in neoplastic human colonic tissues. Biochem. Biophys. Res. Commun. 189:1992;1165-1169
83. Finley G.G., Koski R.A., Melhem M.F., Pipas J.M., Meisler A.I. Expression of the gastrin gene in the normal human colon and colorectal adenocarcinoma. Cancer Res. 53:1993;2919-2926
84. Nemeth J., Taylor B., Pauwels S., Varro A., Dockray G.J. Identification of progastrin derived peptides in colorectal carcinoma extracts. Gut. 34:1993;90-95
85. Van Solinge W.W., Nielsen F.C., Friis-Hansen L., Falkmer U.G., Rehfeld J.F. Expression but incomplete maturation of progastrin in colorectal carcinomas. Gastroenterology. 104:1993;1099-1107
86. Matsushima Y., Kinoshita Y., Nakata H., Inomoto-Naribayashi Y., Asahara M., Kawanami C., et al. Gastrin receptor gene expression in several human carcinomas. Jpn. J. Cancer Res. 85:1994;819-824
87. Ciccotosto G., McLeish A., Hardy K., Shulkes A. Expression processing and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology. 109:1995;1142-1153
88. Imdahl A., Mantamadiotis T., Eggstein S., Farthmann E.H., Baldwin G.S. Expression of gastrin, gastrin/CCK-2 and gastrin/CCK-C receptors in human colorectal carcinomas. J. Cancer Res. Clin. Oncol. 121:1995;661-666
89. Biagini P., Monges G., Vuaroqueaux V., Parriaux D., Cantaloube J.F., De Micco P. The human gastrin/cholecystokinin receptors: type B and type C expression in colonic tumors and cell lines. Life Sci. 61:1997;1009-1018
90. Weinberg D.S., Heyt G.J., Cavanagh M., Pitchon D., McGlynn K.A., London W.T. Cholecystokinin and gastrin levels are not elevated in human pancreatic adenocarcinoma. Cancer Epidemiol. Biomark. Prev. 10:2001;721-722
91. Pichon M.F., Coquin G., Fauveau C., Rey A. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors. Anticancer Res. 19:1999;1445-1450
92. Tang C., Biemond I., Lamers C.B. Expression of peptide receptors in human endocrine tumours of the pancreas. Gut. 40:1997;267-271
93. Reubi J.C., Schaer J.C., Waser B. Cholecystokinin(CCK)-A and CCK-2/gastrin receptors in human tumors. Cancer Res. 57:1997;1377-1386
94. Andren-Sandberg A., Hoem D., Backman P.L. Other risk factors for pancreatic cancer: hormonal aspects. Ann. Oncol. 10(Suppl. 4):1999;131-135
95. McDonald J.M., Longnecker D.S., Bell R.H. Jr. Effect of hypergastrinemia on pancreatic carcinogenesis. Am. J. Surg. 183:2002;441-444
96. Herrington M.K., Gasslander T., Cina R.A., Fehsenfeld D.M., Kazakoff K.R., Pour P.M., et al. Effects of high-fat diet and cholecystokinin receptor blockade on promotion of pancreatic ductal cell tumors in the hamster. Nutr. Cancer. 28:1997;219-224
97. Ogura Y., Matsuda S., Itho M., Sasaki H., Tanigawa K., Shimomura M. Inhibitory effect of loxiglumide (CR 1505), a cholecystokinin receptor antagonist, on N-nitrosobis(2-oxopropyl) amine-induced biliary carcinogenesis in Syrian hamsters. World J. Surg. 26:2002;359-365
98. Saillan-Barreau C., Clerc P., Adato M., Escrieut C., Vaysse N., Fourmy D., et al. Transgenic CCK-2/gastrin receptor mediates murine exocrine pancreatic secretion. Gastroenterology. 115:1998;988-996
99. Yen T.W., Sandgren E.P., Liggitt H.D., Palmiter R.D., Zhou W., Hinds T.R., et al. The gastrin receptor promotes pancreatic growth in transgenic mice. Pancreas. 24:2002;121-129
100. Clerc P., Leung-Theung-Long S., Wang T.C., Dockray G.J., Bouisson M., Delisle M.B., et al. Expression of CCK2 receptors in the murine pancreas: proliferation, transdifferentiation of acinar cells, and neoplasia. Gastroenterology. 122:2002;428-437
101. Yapp R., Modlin I.M., Kumar R.R., Binder H.J., Dubrow R. Gastrin and colorectal cancer. Evidence against an association. Dig. Dis. Sci. 37:1992;481-484
102. Niv Y., Heizelracht N., Lamprecht S.A., Sperber A.D., Fraser G.M., Schwartz B. Gastrin levels in colorectal cancer. Isr. J. Med. Sci. 33:1997;186-189
103. Fontanesi B.V., Boris B., Delcio M., Manoukian F.N. Gastrin levels in patients with colorectal cancer. Hepato-gastroenterol. 44:1997;1082-1084
104. Siddheshwar R., Gray J., Kelly S. Plasma levels of progastrin but not amidated gastrin or glycine extended gastrin are elevated in patients with colorectal carcinoma. Gut. 48:2001;47-52
105. Konturek P.C., Bielanski W., Konturek S.J., Hartwich A., Pierzchalski P., Gonciarz M., et al. Progastrin and cyclooxygenase-2 in colorectal cancer. Dig. Dis. Sci. 47:2002;1984-1991
106. Oscarson J., Veen H., Ross J., Malt R. Dimethylhydrazine induced colonic neoplasia: dissociation from endogenous gastrin levels. Surgery. 91:1982;525-530
107. Chen D., Destree M., Hakanson R., Willems G. Endogenous hypergastrinemia does not promote growth of colonic mucosa or of transplanted colon adenocarcinoma in rats. Eur. J. Gastroenterol. Hepatol. 10:1998;293-299
108. Singh P., Velasco M., Given R., Wargovich M., Varro A., Wang T.C. Mice overexpressing progastrin are predisposed for developing aberrant colonic crypt foci in response to AOM. Am. J. Physiol. 278:2000;G390-G399
109. Fontana M.G., Donato F., Villanacci V., Ghirardi M., Moneghini D., Di Betta E., et al. Inhibitory effect of a gastrin receptor antagonist, CR 2495, on 1, 2-dimethylhydrazine-induced colorectal cancer in mice. Eur. Surg. Res. 31:1999;406-411
110. Fontana M.G., Moneghini D., Villanacci V., Donato F., Rindi G. Effect of cholecystokinin-B gastrin receptor blockade on chemically induced colon carcinogenesis in mice: follow up at 52 weeks. Digestion. 65:2002;35-40
111. Hellmich M.R., Rui X.L., Hellmich H.L., Fleming R.Y., Evers B.M., Townsend C.M. Jr. Human colorectal cancers express a constitutively active cholecystokinin-B/gastrin receptor that stimulates cell growth. J. Biol. Chem. 275:2000;32122-32128
112. Ding W.Q., Kuntz S.M., Miller L.J. A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced cellular U2AF35 and a suboptimal 3′-splicing site leading to retention of the fourth intron. Cancer Res. 62:2002;947-952
113. Smith J.P., Verderame M.F., McLaughlin P., Martenis M., Ballard E., Zagon I.S. Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. Int. J. Mol. Med. 10:2002;689-694
114. Singh P., Velasco M., Given R., Varro A., Wang T.C. Progastrin expression predisposes mice to colon carcinomas and adenomas in response to a chemical carcinogen. Gastroenterology. 119:2000;162-171
115. Cobb S., Wood T., Tessarollo L., Velasco M., Given R., Varro A., et al. Deletion of functional gastrin gene markedly increases colon carcinogenesis in response to azoxymethane in mice. Gastroenterology. 123:2002;516-530
116. Koh T.J., Bulitta C.J., Fleming J.V., Dockray G.J., Varro A., Wang T.C. Gastrin is a target of the beta-catenin/TCF-4 growth signalling pathway in a model of intestinal polyposis. J. Clin. Invest. 106:2000;533-539
117. Watson S.A., Smith A.M. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis. Cancer Res. 61:2001;625-631
118. Nakata H., Wang S., Chung D. Oncogenic ras induces gastrin gene expression in colon cancer. Gastroenterology. 115:1998;1144-1153
119. Luttichau H., Van Solinge W., Nielsen F., Rehfeld J. Developmental expression of the gastrin and cholecystokinin genes in the rat colon. Gastroenterology. 104:1993;1092-1098
120. Thorburn C.M., Friedman G.D., Dickinson C.J., Vogelman J.H., Orentreich N., Parsonnet J. Gastrin and colorectal cancer: a prospective study. Gastroenterology. 115:1998;275-280
121. Watson S.A., Michaeli D., Morris T.M., Clarke P., Varro A., Griffin N., et al. Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV. Eur. J. Cancer. 35:1999;1286-1291
122. Watson S.A., Clarke P.A., Morris T.M., Caplin M.E. Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor. Cancer Res. 60:2000;5902-5907
123. Brett B.T., Smith S.C., Bouvier C.V., Michaeli D., Hochhauser D., Davidson B.R., et al. Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J. Clin. Oncol. 20:2002;4225-4231
124. Behr T.M., Behe M., Angerstein C., Gratz S., Mach R., Hagemann L., et al. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin. Cancer Res. 5:1999;3124s-3138s. (Suppl.)
125. Behr T.M., Behe M.P. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies. Semin. Nucl. Med. 32:2002;97-109
126. 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-2 receptor-targeted scintigraphy and radionuclide therapy. J. Nucl. Med. 40:1999;2081-2087
127. Konturek P.C., Kania J., Kukharsky V., Ocker S., Hahn E.G., Konturek S.J. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells. J. Physiol. Pharmacol. 54:2003;17-32
128. Yao M., Song D.H., Rana B., Wolfe M.M. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. Br. J. Cancer. 87:2002;574-579
129. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev., Cancer. 1:2001;11-21